Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Rapid Bio Logo
Rapid Bio CB Rank
1090632
Heat Score
53
Rapid Bio develops fast and accurate rapid tests for diagnosing antibodies to SARS Cov2 and others.
Founded
obfuscation
Private Bolshoy, Volgograd, Russian Federation rapidbio.ru/
Biotechnology
Health Care
Health Diagnostics
Medical
Overview

Rapid Bio
Heat Score
53

Growth Score
pts
in past quarter
Heat Score 53
-6 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Rapid Bio

CB Rank
1090632
Rapid Bio develops fast and accurate rapid tests for diagnosing antibodies to SARS Cov2 and others.
Founded
obfuscation
Private Bolshoy, Volgograd, Russian Federation rapidbio.ru/
Biotechnology
Health Care
Health Diagnostics
Medical

Details

Legal Name Rapid Bio, LLC
Operating Status Active
Company Type For Profit
Phone Number +7 495 105 99 16
Contact Email info@rapidbio.ru
Predictions & Insights

Growth Insight

See this Growth Insight
Rapid Bio is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction

Products & Services

Rapid test for qualitative detection of antibodies to HIV-1 and HIV-2
A rapid immunochromatographic test to qualitatively detect antibodies to HIV-1 and HIV-2 in human serum, plasma, or whole blood.
Rapid test for qualitative detection of HIV-1 p24 antigen and antibodies to HIV-1 and HIV-2
A rapid immunochromatographic test for simultaneous qualitative detection of HIV-1 p24 antigen and antibodies to HIV-1 and HIV-2 in human serum, plasma, or whole blood.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Contacts 1
News

News and Press

News•Jan 27, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

679
59.76%
 in past month

IT Spend

$3.1MThis year, Rapid Bio is projected to spend $3.1M on IT, according to Aberdeen.

Active Website Tech Count

3Rapid Bio is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, Euro, and  CommonCrawl Top 5m.

Total IP

1Rapid Bio has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Rapid Bio's headquarters? Rapid Bio is located in Bolshoy, Volgograd, Russian Federation.Who are Rapid Bio's competitors? Alternatives and possible competitors to Rapid Bio may include Abbott, OraSure Technologies, and  Chembio Diagnostic Systems Inc..
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3e39328 1)
|